DB15080InvestigationalSmall molecule
ELX-02 is under investigation in clinical trial NCT03309605 (Phase 1 Study of ELX-02 in Healthy Adult Subjects).
- Formula / weight
- C19H38N4O10 · 482.531 g/mol (avg)
- Code names
- ELX-02
Resolves to
Structure
InChIKey
KJBRSTPUILEBDR-YBNFDXCTSA-NSMILESC[C@@H](N)[C@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H]([C@@H](C)O)[C@@H](O)[C@H](O)[C@H]2N)[C@H](O)[C@@H]1OWhat you can answer from here — as of April 23, 2025
Which companies are running trials of ELX-02, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account